Profile

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, currently based in New York City. The company markets pharmaceutical solutions for anti-viral smallpox treatment. The company trades publicly as SIGA on NASDAQ. In September 2009, SIGA Technologies received a $1.6 million research fund from the National Institutes of Health for its broad-spectrum antiviral candidates.